Monday 8 June 2026

One To Watch

OnKure Therapeutics

A privately-held, clinical-stage biopharmaceutical developing novel precision medicines in oncology.

Company Overview

Want to Update your Company's Profile?


Latest OnKure Therapeutics News

Reneo Pharma to merge with OnKure
14 May 2024
More OnKure Therapeutics news >


Today's issue

The week in pharma: action, reaction and insight – week to June 5, 2026
Pharmaceutical
The week in pharma: action, reaction and insight – week to June 5, 2026
7 June 2026
Pharmaceutical
EC nod for Chiesi’s Lojuxta for pediatric HoFH patients
6 June 2026
Biotechnology
Seres strengthens balance sheet with $25 million Nestlé deal
6 June 2026
Pharmaceutical
No changes to Takeda’s core financials, despite $2.5 billion legal provision
5 June 2026
Generics
Russia aims to have generic of one of the most expensive cystic fibrosis drugs
5 June 2026
Pharmaceutical
An inconvenient truth? Japan, innovation, drug pricing, MFN
5 June 2026
Biotechnology
Phase III data show less kidney function decline with Voyxact in IgAN
5 June 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze